Gracien et al., 2016 - Google Patents
Multimodal quantitative MRI assessment of cortical damage in relapsing‐remitting multiple sclerosisGracien et al., 2016
View PDF- Document ID
- 16093491647473899078
- Author
- Gracien R
- Jurcoane A
- Wagner M
- Reitz S
- Mayer C
- Volz S
- Hof S
- Fleischer V
- Droby A
- Steinmetz H
- Groppa S
- Hattingen E
- Deichmann R
- Klein J
- Publication year
- Publication venue
- Journal of Magnetic Resonance Imaging
External Links
Snippet
Purpose To investigate magnetization transfer ratio (MTR), T1 relaxation time, and proton density (PD) as indicators of gray matter damage in relapsing‐remitting multiple sclerosis (RRMS), reflecting different aspects of microstructural damage and as imaging correlates of …
- 230000001054 cortical 0 title abstract description 70
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56341—Diffusion imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gracien et al. | Multimodal quantitative MRI assessment of cortical damage in relapsing‐remitting multiple sclerosis | |
Guan et al. | Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping | |
Gracien et al. | Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex | |
Fujiwara et al. | High‐resolution diffusion tensor imaging for the detection of diffusion abnormalities in the trigeminal nerves of patients with trigeminal neuralgia caused by neurovascular compression | |
Xu et al. | Application and evaluation of NODDI in the cervical spinal cord of multiple sclerosis patients | |
O'Muircheartaigh et al. | Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis | |
de Kouchkovsky et al. | Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study | |
Hasan et al. | Diffusion tensor fractional anisotropy of the normal‐appearing seven segments of the corpus callosum in healthy adults and relapsing‐remitting multiple sclerosis patients | |
Maraka et al. | Degree of corticospinal tract damage correlates with motor function after stroke | |
Vemuri et al. | Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging | |
Price et al. | The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study | |
Bester et al. | Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis | |
Giorgio et al. | Relationships of brain white matter microstructure with clinical and MR measures in relapsing‐remitting multiple sclerosis | |
Kamiya et al. | Diffusion imaging of reversible and irreversible microstructural changes within the corticospinal tract in idiopathic normal pressure hydrocephalus | |
Rowley et al. | Age‐related mapping of intracortical myelin from late adolescence to middle adulthood using T1‐weighted MRI | |
Samaraweera et al. | The central vein sign in multiple sclerosis lesions is present irrespective of the T2* sequence at 3 T | |
Jurcoane et al. | Within‐lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis | |
Gracien et al. | Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry | |
Yu et al. | Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging | |
Zhou et al. | High resolution diffusion tensor imaging of human nerves in forearm | |
Lorio et al. | MRI profiling of focal cortical dysplasia using multi‐compartment diffusion models | |
Palesi et al. | DTI and MR Volumetry of Hippocampus‐PC/PCC Circuit: In Search of Early Micro‐and Macrostructural Signs of Alzheimers′ s Disease | |
Johnson et al. | Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study | |
By et al. | Multi‐compartmental diffusion characterization of the human cervical spinal cord in vivo using the spherical mean technique | |
Gracien et al. | Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: a pilot study |